[Immunological studies and immunotherapeutic possibilities in inoperable bronchogenic carcinoma (author's transl)].
By establishing an immune profile combined with detailed clinical observation an attempt was made to assess the value of various therapeutic measures, especially immunological methods, in the treatment of inoperable bronchogenic carcinoma. The results indicated that in advanced cases specific immunological measures or stimulation of the immune mechanism only play a supportive role. Toxic side-effects or tumour enhancement were absent.
D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis; D001500:BCG Vaccine; D002283:Carcinoma, Bronchogenic / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002464:Cell Migration Inhibition; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000276:immunology*; D008213:Lymphocyte Activation; D008297:Male; D009108:Mumps Vaccine / Q000627:therapeutic use; D014801:Vitamin A / Q000627:therapeutic use
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D009108:Mumps Vaccine; D014801:Vitamin A; D003520:Cyclophosphamide
Immunologische Untersuchungen und immuntherapeutische Möglichkeiten beim inoperablen Lungenkarzinom.